Monographie - Dexrazoxane hydrochloride

Poslední aktualizace :
16/06/2024

Dexrazoxane hydrochloride

Chemický vzorec

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cardioxane	äpanÏlsko, BrazÌlie, Chile, Dánsko, Ekvádor, Francie, Irsko, Itálie, MaÔarsko, Mexiko, NÏmecko, Peru, Polsko, Rakousko, Velká Británie, Venezuela
Cyrdanax	Francie, NÏmecko
Dexrazoxane	Ekvádor, USA
Dexrazoxano	Mexiko, Peru
Razox	Peru
Razoxane	Kolumbie
Rhianta	Mexiko
Savene	äpanÏlsko, Belgie, Dánsko, Finsko, Francie, Irsko, Itálie, MaÔarsko, NÏmecko, Nizozemsko, Norsko, Polsko, Rumunsko, Švédsko, Velká Británie, ÿecko
Zinecard	Kanada, USA
Zucordex	Mexiko

Odkazy : Dexrazoxane hydrochloride

	Typ	Uveřejnění
381	Noviny	Beijnen JH, Van Gijn R. Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids. J Parenter Sci Technol 1993 ; 47: 166-171.
1423	Noviny	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1754	Noviny	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1949	Noviny	Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies. Clinical Cancer Research 2001 ; 7: 1569-1576.
1953	Noviny	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
2201	Noviny	Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B. Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers. EJHP Science 2007 ; 13, 3: 55-59.
2224	Noviny	Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P. Dexrazoxane: Stabilià in soluzione. Bolletino SIFO 2007 ; 53: 178-180.
3581	Laboratoř	Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit Clinigen Healthcare 2013
3611	Noviny	Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T. Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions. J Oncol Pharm Practice 2014 ; 20, 1: 58-64.

Mentions Légales